Business Description
MYND Life Sciences Inc
NAICS : 325412
SIC : 3741
ISIN : CA62857B1094
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -7.92 | |||||
Debt-to-Equity | -0.54 | |||||
Debt-to-EBITDA | -10.91 | |||||
Piotroski F-Score | 5/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 20.69 | |||||
14-Day RSI | 22 | |||||
6-1 Month Momentum % | -44.93 | |||||
12-1 Month Momentum % | -26.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.11 | |||||
Quick Ratio | 0.11 | |||||
Days Payable | 1843.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -72.8 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -116.77 | |||||
ROIC % | -40.77 | |||||
ROC (Joel Greenblatt) % | -2000 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -12.59 | |||||
EV-to-EBITDA | -12.64 | |||||
EV-to-FCF | -15.66 | |||||
Earnings Yield (Greenblatt) % | -7.94 | |||||
FCF Yield % | -46.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MYNDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MYND Life Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.015 | ||
Beta | 0.52 | ||
Volatility % | 103.83 | ||
14-Day RSI | 22 | ||
14-Day ATR ($) | 0.000013 | ||
20-Day SMA ($) | 0.0125 | ||
12-1 Month Momentum % | -26.9 | ||
52-Week Range ($) | 0.0125 - 0.0312 | ||
Shares Outstanding (Mil) | 47.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MYND Life Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MYND Life Sciences Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
MYND Life Sciences Inc Frequently Asked Questions
What is MYND Life Sciences Inc(MYNDF)'s stock price today?
When is next earnings date of MYND Life Sciences Inc(MYNDF)?
Does MYND Life Sciences Inc(MYNDF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |